Carroll Financial Associates’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-19,431
Closed -$39K 1337
2018
Q3
$39K Hold
19,431
﹤0.01% 554
2018
Q2
$35K Hold
19,431
﹤0.01% 557
2018
Q1
$45K Buy
+19,431
New +$45.6K ﹤0.01% 509
2017
Q4
Sell
-19,431
Closed -$47K 1264
2017
Q3
$47K Hold
19,431
0.01% 502
2017
Q2
$53K Hold
19,431
0.01% 483
2017
Q1
$58K Hold
19,431
0.01% 448
2016
Q4
$61K Hold
19,431
0.01% 427
2016
Q3
$66K Hold
19,431
0.01% 419
2016
Q2
$44K Hold
19,431
0.01% 466
2016
Q1
$48K Sell
19,431
-1,632
-8% -$3.64K 0.01% 434
2015
Q4
$69K Hold
21,063
0.01% 348
2015
Q3
$63K Hold
21,063
0.01% 352
2015
Q2
$62K Buy
+21,063
New +$81.7K 0.01% 336

Other funds holding LCTX